IS:SUVEN Suven Life Sciences Limited

Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, designs, manufactures, and supplies bulk actives, drug intermediates, and specialty chemicals for the life science companies worldwide. It provides intermediates and active pharmaceutical ingredients, as well as stock chemicals. The company also offers contract research and manufacturing services, including development and supply of pharmaceutical and agro chemical intermediates for new chemical entities. In addition, it provides discovery and development of new chemical entities for CNS disorders; research collaborative projects with pharmaceutical companies; and drug discovery research services, such as in-vitro screening and molecular biology, drug metabolism and pharmacokinetics, pharmacology, toxicology, and bioanalysis, as well as operates a formulation development center. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. Suven Life Sciences Limited was founded in 1989 and is based in Hyderabad, India. Suven Life Sciences Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.

93.60 INR
As of 01/17/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  India
Country of incorporation:  India
IPO date:  10/24/2003
Stock exchange:    National Stock Exchange O
Exchange country:   India
Market cap:   12,390,902,784 INR
Current dividend yield:   2.46%
Sedol:      B1VJ4Z5

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy